INDUCTION HEALTHCARE GROUP PLC

Regulatory Filings • Jan 17, 2023

National Storage Mechanism | Additional information

RNS Number : 8996M

Induction Healthcare Group PLC

17 January 2023

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

Change of Registered Office

Induction (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, announces a change in its registered office address.

With immediate effect the new registered office address is c/o Pinsent Masons, 30 Crown Place, Earl Street, London, EC2A 4ES.

ENQUIRIES

Induction Christopher Samler, Executive Chair Paul Tambeau, Chief Operating Officer	Via Walbrook PR Ltd: induction@walbrookpr.com
Singer Capital Markets (Nominated Adviser and Broker)	+44 (0)20 7496 3000
Philip Davies
Walbrook PR Ltd	induction@walbrookpr.com
Paul McManus / Kiki Zaccagnini	Mob: +44 (0)7980 541 893 / +44 (0)7387 744 286

About Induction - www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CROFZGMMRVFGFZM